Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.84 USD | +7.42% | -3.16% | -23.75% |
May. 20 | Chinese Regulator Approves Zai Lab’s New Drug Application for Bacterial Pneumonia Drug | MT |
May. 20 | Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.75% | 1.92B | |
-3.15% | 90.45B | |
+3.95% | 41.45B | |
-10.51% | 33.57B | |
+60.58% | 25.73B | |
-20.09% | 14.73B | |
-8.92% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.17% | 8.79B |
- Stock Market
- Equities
- ZLAB Stock
- News Zai Lab Limited
- Citigroup Raises Price Target for Zai Lab to $231 From $217, Maintains Buy Rating